Defence Therapeutics Pays $160,000 in Interest With 320,000 Shares

Bitget2026/10/23 20:16

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Defence Therapeutics issued 320,000 common shares to settle $160,000 in accrued, unpaid interest on convertible debentures.
The debentures, dated September 15, 2025, have a $2 million principal amount and bear 8% annual interest.
The interest shares carry a statutory hold period of four months and one day.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Defence Therapeutics Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610231615NEWSFILECNPR____20261023_320679_1) on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Defence Therapeutics Pays $160,000 in Interest With 320,000 Shares

You may also like

Crypto prices